Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MMG ( (HK:1208) ) has issued an announcement.
MMG’s subsidiary Minera Las Bambas (MLB) has signed a molybdenum concentrate sales framework agreement with China Minmetals Non-ferrous Metals (CMN) covering 2026–2028, formalising ongoing sales of molybdenum concentrate from the Las Bambas operation to CMN and its affiliates. The transaction is classified as a continuing connected transaction under Hong Kong listing rules, triggering reporting, annual review and announcement requirements but remaining exempt from independent shareholder approval; pricing will be set on an arm’s-length basis with reference to S&P Platts market quotations and discounts benchmarked against independent third-party offers, aiming to ensure sales terms are no less favourable than those to external customers and providing MMG with continued offtake certainty for molybdenum while maintaining regulatory compliance on related-party dealings.
The most recent analyst rating on (HK:1208) stock is a Buy with a HK$8.50 price target. To see the full list of analyst forecasts on MMG stock, see the HK:1208 Stock Forecast page.
More about MMG
MMG Limited is a Hong Kong-incorporated resources company engaged in the exploration, development and production of base metals, with operations that include the Las Bambas mine in Peru. The company produces and markets concentrates of copper and associated by-products such as molybdenum, supplying these to global metals traders and industrial customers, with a particular focus on the Chinese market through related parties within the China Minmetals corporate network.
Average Trading Volume: 60,570,256
Technical Sentiment Signal: Buy
Current Market Cap: HK$103.6B
For a thorough assessment of 1208 stock, go to TipRanks’ Stock Analysis page.